Brain, Vol. 118, No. 6, 1573-1581, 1995
© 1995 Guarantors of Brain
research-article |
Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies)
Clinical and neuropathological analysis of 53 patients from three unrealted SCA2 families
1INSERM U289, Hópitual de la Satpêtrière Paris, France 2Service Central d'Anatomie et de Cytologie Pathologiques, Hópital Lariboisière Paris, France 3INSERM U114, Collè de France Paris, France 4Service de Neurologie, Hôpital Pierre Zobda-Quitman Fort-de-France 5Laboratoire de Biologie Moléculaire, CTS-HÔpital Pierre Zobda-Quitman Fort-de-France, Martinique, French west Indies
Correspondence to:
Correspondence to: Alexis Brice, INSERM U289, Hôpital de la Salpêtrière, 47 bd de I'Hôpital, 75651 Paris Cedex 13, France
Autosomal dominant cerebettar ataxia type I was diagnosed in three unrelated families from Martinique (French West Indies), and linkage to the locas for spinocerebellar ataxia 2(SCA2) was established. Neuropathotogical findings in two patients were those of olivopontocerebellar atrophy without oligodendroglial cytoplasmic inclusions. Cerebellar ataxia was associated with hyporeflexia in 68% of 31 examined patients, with stawed and/or limited eye movements in 65% and with dementia in 29%. No patients had optic atrophy, pigmentary retinal degeneration, spasticity or parkinsonism. Mean age at onset was 33±16 years, and onset before the age of 20 years was correlated with a more rapid and severe course of the disease. Movement dixonders, oculomotor disturbunces, sphincter disturbances and congnitive impairment were significantly more frequent in early than in late onset patients. This explains why the phenotype was strikingly different in one family, in which mean age at onset was much earlier. Comparison with previously described SCA2 families indicated similarities, such as reduced saccade velocity, supranuclear opthalmoplegia and decreased reflexes, although phenotypic heterogeneity remains the outstanding feature of this disorder
autosomal dominant cerebellar ataxia type 1; spinocerebellar ataxia 2; olivopontocerebellar atrophy; phenotypic heterogeneity
Received June 2, 1995. Accepted July 22, 1995.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. B. Ramocki, L. Chapieski, R. O. McDonald, F. Fernandez, and A. D. Malphrus Spinocerebellar Ataxia Type 2 Presenting With Cognitive Regression in Childhood J Child Neurol, September 1, 2008; 23(9): 999 - 1001. [Abstract] [PDF] |
||||
![]() |
M Suenaga, Y Kawai, H Watanabe, N Atsuta, M Ito, F Tanaka, M Katsuno, H Fukatsu, S Naganawa, and G Sobue Cognitive impairment in spinocerebellar ataxia type 6 J. Neurol. Neurosurg. Psychiatry, May 1, 2008; 79(5): 496 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Charles, A. Camuzat, N. Benammar, F. Sellal, A. Destee, A-M Bonnet, S. Lesage, I. Le Ber, G. Stevanin, A. Durr, et al. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology, November 20, 2007; 69(21): 1970 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.L. Mandelli, T. De Simone, L. Minati, M.G. Bruzzone, C. Mariotti, R. Fancellu, M. Savoiardo, and M. Grisoli Diffusion Tensor Imaging of Spinocerebellar Ataxias Types 1 and 2 AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1996 - 2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Kim, S. Hong, G. P. Kim, Y. J. Choi, Y. K. Kim, S. S. Park, S. E. Kim, and B. S. Jeon Importance of Low-Range CAG Expansion and CAA Interruption in SCA2 Parkinsonism Arch Neurol, October 1, 2007; 64(10): 1510 - 1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Boesch, J Muller, G K Wenning, and W Poewe Cervical dystonia in spinocerebellar ataxia type 2: clinical and polymyographic findings J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 520 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lasek, R. Lencer, C. Gaser, J. Hagenah, U. Walter, A. Wolters, N. Kock, S. Steinlechner, M. Nagel, C. Zuhlke, et al. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17) Brain, September 1, 2006; 129(9): 2341 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Wullner, M. Reimold, M. Abele, K. Burk, M. Minnerop, B.-M. Dohmen, H.-J. Machulla, R. Bares, and T. Klockgether Dopamine Transporter Positron Emission Tomography in Spinocerebellar Ataxias Type 1, 2, 3, and 6 Arch Neurol, August 1, 2005; 62(8): 1280 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guerrini, F. Lolli, A. Ginestroni, G. Belli, R. D. Nave, C. Tessa, S. Foresti, M. Cosottini, S. Piacentini, F. Salvi, et al. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study Brain, August 1, 2004; 127(8): 1785 - 1795. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Lu, Y.-H. Wu Chou, P.-C. Kuo, H.-C. Chang, and Y.-H. Weng The Parkinsonian Phenotype of Spinocerebellar Ataxia Type 2 Arch Neurol, January 1, 2004; 61(1): 35 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Rub, D. Del Turco, K. Del Tredici, R. A. I. de Vos, E. R. Brunt, G. Reifenberger, C. Seifried, C. Schultz, G. Auburger, and H. Braak Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance Brain, October 1, 2003; 126(10): 2257 - 2272. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Pang, P. Giunti, S. Chamberlain, S. F. An, R. Vitaliani, T. Scaravilli, L. Martinian, N. W. Wood, F. Scaravilli, and O. Ansorge Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases Brain, March 1, 2002; 125(3): 656 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schwenkreis, M. Tegenthoff, K. Witscher, C. Bornke, H. Przuntek, J.-P. Malin, and L. Schols Motor cortex activation by transcranial magnetic stimulation in ataxia patients depends on the genetic defect Brain, February 1, 2002; 125(2): 301 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schols, S. Peters, S. Szymanski, R. Kruger, S. Lange, C. Hardt, O. Riess, and H. Przuntek Extrapyramidal Motor Signs in Degenerative Ataxias Arch Neurol, October 1, 2000; 57(10): 1495 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Restituito, R. M. Thompson, J. Eliet, R. S. Raike, M. Riedl, P. Charnet, and C. M. Gomez The Polyglutamine Expansion in Spinocerebellar Ataxia Type 6 Causes a beta Subunit-Specific Enhanced Activation of P/Q-Type Calcium Channels in Xenopus Oocytes J. Neurosci., September 1, 2000; 20(17): 6394 - 6403. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Burk, C. Globas, S. Bosch, S. Graber, M. Abele, A. Brice, J. Dichgans, I. Daum, and T. Klockgether Cognitive deficits in spinocerebellar ataxia 2 Brain, April 1, 1999; 122(4): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Geschwind Focusing Attention on Cognitive Impairment in Spinocerebellar Ataxia Arch Neurol, January 1, 1999; 56(1): 20 - 22. [Full Text] [PDF] |
||||
![]() |
E. Storey, S. M. Forrest, J. H. Shaw, P. Mitchell, and R. J. M. Gardner Spinocerebellar Ataxia Type 2: Clinical Features of a Pedigree Displaying Prominent Frontal-Executive Dysfunction Arch Neurol, January 1, 1999; 56(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schols, S. Gispert, M. Vorgerd, A. M. M. Vieira-Saecker, P. Blanke, G. Auburger, G. Amoiridis, S. Meves, J. T. Epplen, H. Przuntek, et al. Spinocerebellar Ataxia Type 2: Genotype and Phenotype in German Kindreds Arch Neurol, September 1, 1997; 54(9): 1073 - 1080. [Abstract] [PDF] |
||||






